| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| UNII: | S9U4ZR2W8V |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lymphoma, Large B-Cell, Diffuse | 3 | D016403 | ClinicalTrials |
| Lymphoma, Follicular | 3 | D008224 | ClinicalTrials |
| Lymphoma | 2 | D008223 | ClinicalTrials |
| Leukemia | 2 | D007938 | ClinicalTrials |
| Multiple Myeloma | 2 | D009101 | ClinicalTrials |
| Graft vs Host Disease | 2 | D006086 | ClinicalTrials |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | D054198 | ClinicalTrials |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | D015451 | ClinicalTrials |
| Hodgkin Disease | 1 | D006689 | ClinicalTrials |
| Waldenstrom Macroglobulinemia | 1 | D008258 | ClinicalTrials |
| Lymphoma, AIDS-Related | 1 | D016483 | ClinicalTrials |
| Neoplasms, Plasma Cell | 1 | D054219 | ClinicalTrials |
| Burkitt Lymphoma | 1 | D002051 | ClinicalTrials |
| Lymphoma, B-Cell, Marginal Zone | 1 | D018442 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2108610 |
| FDA SRS | S9U4ZR2W8V |
CONTENTS